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Abstract It has been noted that national life expectancies
have diverged in Europe in recent decades, but it is unknown
how these recent trends compare to longer term developments.
Data on life expectancy, cause-specific mortality and deter-
minants of mortality were extracted from harmonized
international data-bases. Variation was quantified with the
inter-quartile range, and the contribution of changing eco-
nomic conditions was analyzed by comparing observed life
expectancy variations with those expected on the basis of
changes in levels of national income and/or changes in the
relation between national income and life expectancy. During
the first decades of the 20th century, variation in life expectancy
in Europe increased to reach peak values around 1920, then
decreased to reach its lowest values in 1960 (among men) and
1970 (among women), and finally increased strongly again.
The first widening was due to less rapid decline in mortality in
Southern and Central and Eastern Europe, particularly from
infectious diseases, and coincided with an increasing strength
of the national income—life expectancy relation. The second
widening was due to stagnating or increasing mortality in
Central and Eastern Europe, particularly from cardiovascular
diseases, and coincided with a very strong rise of between-
country differences in national income. Despite some simi-
larities, differences between both episodes of widening
differences in life expectancy cast doubt on the idea that the
current episode of widening represents a simple delay of epi-
demiological transitions. Instead, it is an alarming phenome-
non that should be a main focus of European policy making.
Keywords Life expectancy  Mortality  Europe  History 
Epidemiologic transition
Introduction
During the 20th century, life expectancy in Europe has
risen strongly, but with important variations in both time
and space. In Fig. 1 we have plotted all available national
life expectancies in a single graph, leaving out the two
main ‘mortality crises’ of 1914-1919 (caused by World
War I and an influenza pandemic) and 1940-1945 (World
War II). Apart from a steady rise in life expectancy we see
some major local interruptions (e.g. in the 1930s, caused by
Stalin’s collectivization of agriculture in Ukraine and
Russia [1] and by the Spanish Civil War [2]), and a clear
dispersion in recent decades.
This recent divergence, which is mainly due to stag-
nation and sometimes decline of life expectancy in
Central and Eastern Europe, has not gone unnoticed
[3–7]. Studies have shown that recent unfavorable mor-
tality trends in Central and Eastern Europe are largely due
to unfavorable trends in mortality from cardiovascular
diseases, caused by various circumstances linked to the
political and economic situation in the communist and
post-communist era, such as dietary problems, excessive
alcohol consumption, lack of access to adequate health
care, unemployment, poverty and psychosocial stress
[8–12].
It is unknown, however, how these recent trends compare
to longer term developments in life expectancy. As Fig. 1
suggests, this may not be the first episode of widening of the
life expectancy gap in Europe. As will be more fully
demonstrated later, an earlier episode occurred in the first
decades of the 20th century. Is the current widening more or
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less severe than the earlier one? Did it have the same
causes? Is there a general explanation that can account for
both episodes of widening?
The concept that is most often used to explain long-
term trends in mortality is that of the ‘epidemiologic
transition’. This relates trends in mortality to socioeco-
nomic and other developments which bring both health
benefits and new health risks [13, 14]. During the epi-
demiologic transition, which in different parts of Europe
began between 1850 and 1920 [15], mortality declined
precipitously and life expectancy rose in a spectacular
manner, often in parallel with economic growth. What we
generally see is rapid growth of life expectancy until about
1950–1970, followed by a few decades of stagnation, and
then renewed growth of life expectancy starting in the
period 1970–1990 (Fig. 1).
This sequence of growth, stagnation and renewed
growth of life expectancy corresponds with three succes-
sive stages of epidemiologic transition. During the age of
‘receding pandemics’ life expectancy rises due to declining
infectious disease mortality. This is followed by the age of
‘degenerative and man-made diseases’, during which life
expectancy stagnates due to rising mortality from cardio-
vascular diseases, various cancers and road traffic injuries
[13]. The rise of these ‘diseases of affluence’ is often seen
as a negative side-effect of the economic growth that
helped to reduce infectious disease mortality [16, 17].
Finally, a ‘fourth stage’ sets in during which life expec-
tancy rises again, mainly due to declining mortality from
cardiovascular diseases [18].
It has been argued that rapid declines in mortality are
often accompanied by growing disparities, e.g. between
countries, regions within the same country, or socioeco-
nomic groups, and that the recent divergence of mortality
and life expectancy trends in Europe is simply to be
expected as a corollary of the latest stage in the epidemi-
ologic transition [19, 20]. The reason is that innovations
which reduce mortality are usually first implemented in
some countries and then slowly diffuse to others [21]. This
is an appealing notion, but it carries the risk that diverging
life expectancy is seen as a ‘normal’ phenomenon that will
inevitably disappear when a natural process of diffusion is
allowed to continue.
Empirical evidence for the idea that divergence
accompanies mortality decline, spanning both episodes of
divergence of life expectancy during the 20th century, is
scarce. Therefore, the aims of this paper are:
• to quantify variation in life expectancy in Europe over
the whole period 1900–2008, and to systematically
compare tendencies of convergence and divergence
over time;
• to assess whether the two episodes of divergence in life
expectancy coincided with rapid but differential
declines of mortality from infectious diseases and
cardiovascular diseases, respectively;
• and to assess whether the two episodes of divergence in
life expectancy coincided with similar socioeconomic
developments, e.g. rapid rises in national income and/or
rising variations in national income.
Where available data permit, the analyses will cover the
whole of Europe, not the European Union only.
Fig. 1 Life expectancy trends in Europe, 1900–2008, by gender
a Men b Women
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Data and methods
Because our analysis aimed at understanding the recent
widening of the gap in life expectancy, we decided to
retrospectively collect data for all currently existing states
in Europe, ignoring changes in the political map of Europe
during the 20th century. We defined Europe as the WHO
European region, minus Central Asia and Turkey, minus
mini-states like Monaco. Because this implied that we
would treat the constituent parts of the former Yugoslavia
and Soviet Union as separate units we also divided the
United Kingdom in 3 constituent parts (England & Wales,
Scotland and Northern Ireland). This gave us more than 40
national units from all over Europe to work with.
Because data for the earlier part of the 20th century were
available for a limited number of countries only, with
limited representation of Central and Eastern Europe, we
present some of the analyses for two sets of countries: the
whole of Europe (all available countries) and Western
Europe only. In order to reduce the amount of material to
be presented, most of the analyses use data for selected
points in time (i.e., 1900, 1910, 1920, 1939, 1950, 1960,
1970, 1980, 1990, 2000, 2008). We ignored the years
coinciding with both World Wars, and for the same reason
we chose the year 1939 instead of 1940 when we restricted
the analysis to selected points in time.
For each of the national units, and for their predecessors
in earlier times, we collected data on life expectancy at
birth, by gender, for the period 1900–2008. Although more
recent data were available for some countries, we decided
to take 2008, for which data were nearly complete, as the
last year of the analysis. The primary source of life
expectancy data has been the Human Life table Database
(www.lifetable.de), and this was supplemented by the
World Health Organization Health for All Database (http://
data.euro.who.int/hfadb/), the United Nations Demographic
Yearbook Historical Supplement, 1948-1997 (http://unstats.
un.org/unsd/demographic/products/dyb/DYBHist/HistTab
09a.pdf), the Mesle´ Vallin Data Base [22] and various
other sources [1, 23, 24]. These life expectancy values
cover whole national populations and have very narrow
confidence intervals, and we have therefore refrained from
performing statistical tests.
In order to quantify the magnitude of variations between
countries we tried various measures of dispersion
(e.g., range, standard deviation, standard deviation/average,
inter-quartile range, inter-quartile range/median). Because
the inter-quartile range is least sensitive to outliers and
proved to be robust even when the number of countries was
relatively small, we present results based on this measure.
We also collected data on mortality by cause of death.
For the pre-1970 period age-standardized mortality data
were extracted from a compendium of International
Mortality Statistics [25]. Because these data were presented
in the form of Standardized Mortality Ratios, we re-cal-
culated them as age-standardized mortality rates in order to
be able to make a direct comparison with data for other
periods. For the analysis of the 1970–2008 period age-
standardized mortality data were extracted from the World
Health Organization Health for All Database (http://
data.euro.who.int/hfadb/). ICD-code numbers are given in
the Appendix.
Data on national income per head of population were
extracted from the dataset on Statistics of World Population,
GDP and Per Capita GDP, 1–2008 (http://www.ggdc.net/
MADDISON/oriindex.htm). In contrast to other datasets,
such as the Penn World Tables, this dataset is comprehensive
in its coverage across time and space, and therefore provided
us with data on national income for almost all European
countries and the whole of the 20th century. The national
estimates of Gross Domestic Product per head of population
in this dataset are based on extensive harmonization efforts
and on a conversion into 1990 International Geary-Khamis
dollars using multilateral Purchasing Power Parities. A more
detailed explanation of these data has been published else-
where [26].
In order to analyze the role of socioeconomic develop-
ment in convergence and divergence of life expectancy, we
regressed life expectancy on Gross Domestic Product for
each of the selected points in time (i.e., 1900, 1910, 1920,
1939, 1950, 1960, 1970, 1980, 1990, 2000, 2008). We used
ordinary least squares linear regression, because the rela-
tion between national income and life expectancy was
linear within the range of values observed at each point in
time. We then used the regression parameters (i.e., inter-
cept and slope) to calculate each country’s expected life
expectancy in three ways: [1] as expected on the basis of its
GDP and the GDP—life expectancy relationship as found
at that point in time; [2] as expected on the basis of its
current GDP and the GDP—life expectancy relationship as
found in 1950; and [3] as expected on the basis of its GDP
in 1950 and the current GDP—life expectancy relationship.
This procedure, which was inspired by Preston’s seminal
work on the impact of economic development on life
expectancy [27, 28], allowed us to assess to what extent
convergence and divergence of life expectancy followed
convergence and divergence of national income, or chan-
ges in the relation between national income and life
expectancy.
Results
The patterns of convergence and divergence observed in
Fig. 1 are confirmed by the quantitative analysis presented
in Table 1. During the first decades of the 20th century, the
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inter-quartile range of life expectancy in Europe rose
substantially, and then declined to reach its lowest values
in 1960 (among men) and 1970 (among women). After
that, however, it started to increase again, to reach values in
2008 that were similar to those seen before World War II.
As mentioned in the Introduction, developments before
World War II were partly determined by extraordinary
events in Russia, Ukraine, and Spain occurring during the
1930s. We therefore repeated the analysis without these
three countries, and found that for both men and women
the inter-quartile range of life expectancy reached its
highest value in 1920, rising from 6.33 in 1900 to 8.23 in
1920 among men, and from 6.55 in 1900 to 8.14 in 1920
among women (results not shown). When we restrict the
analysis to Western Europe only, we see that the first
episode of widening also occurred in this part of the sub-
continent, again with peak values for the inter-quartile
range in 1920, but that the second did not (women) or only
to a limited extent (men) (Table 1). This implies that the
most recent episode of widening is almost entirely due to
developments in Central and Eastern Europe.
Figures 2a–d show trends in age-standardized mortality
from all causes during the same time-period. Because the
data come from two different sources, with subtle differ-
ences in data and methods, the trend lines have not been
connected. The three trend-lines represent the life expec-
tancy values corresponding to the first, second and third
quartiles, respectively. In the first sub-period, all three
trend lines declined spectacularly, both among men and
among women, but at first this decline was more rapid in
some countries than in others, as is clear from the diver-
gence between the trend lines. This divergence occurred
both in Europe as a whole and in Western Europe only. In
the second sub-period we see the trend lines starting to
decline and diverge again, but in this case the divergence is
not seen in Western Europe, so must again be due to
developments in Central and Eastern Europe.
The first episode of widening occurred in a period of
rapid mortality decline, mainly because of declining mor-
tality from infectious diseases, as can be seen in Fig. 3. The
trend lines for the first and third quartile in Fig. 3a–b show
that some countries lagged behind in their decline of mor-
tality from infectious diseases, which led to a substantial
gap in mortality from these causes. Inspection of the
underlying data shows that the countries lagging behind
were either in Southern Europe (represented in our data-set
by Spain, Portugal, Greece) or in Central and Eastern
Europe (represented in our data-set by Czechoslovakia,
Hungary, Bulgaria) (results not shown). The second episode
of widening occurred in a period of beginning mortality
decline, driven by declining mortality from cardiovascular
disease. Figures 3c–d show that there were substantial dif-
ferences between countries in the starting year of mortalityT
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decline for cardiovascular diseases, and that mortality still
went up in some countries while it already declined in some
others, particularly among men. The countries lagging
behind were all in Central and Eastern Europe (results not
shown). This led to a large gap in mortality from these
causes.
As Table 2 shows, absolute differences between coun-
tries in national income have increased throughout the
study-period. Relative differences, on the other hand, were
more or less stable until 1980, and then climbed to reach a
peak in 2000. Unlike previous rises of the gap in income,
the recent rise is partly due to declining income in some
parts of Europe (not shown in the table). The association
between national income and life expectancy has always
been positive. The strength of the association (as measured
by the slope parameter) increased between 1900 and 1920,
and then slowly declined to reach much lower values in
1980, after which the strength of the association has
remained stable. The most recent slope parameter, for
2008, still indicates that for each I$1000 increase in
national income, life expectancy rises by 0.54 (men) or
0.37 (women) years. In terms of correlation coefficients the
relation has become even stronger to reach similar levels as
those seen before World War II in recent decades.
Figure 4a shows that changes in the range of variation of
Gross Domestic Product (GDP), and/or in the relation
between GDP and life expectancy, are a reasonably good
predictor of convergence and divergence of life expectancy.
Both episodes of widening can to some extent be ‘predicted’
on the basis of a simple regression of life expectancy on
Fig. 2 Variation in age-standardized death rates in Europe,
1901–2008, all causes, by gender a Quartile values, Europe, men
b Quartile values, Western Europe, men c Quartile values, Europe,
women d Quartile values, Western Europe, women. Notes: ASDR
age-standardized death rate, Q1 age-standardized death rate at first
quartile, Q2 age-standardized death rate at second quartile or median,
Q3 age-standardized death rate at third quartile. IQR = Inter-quartile
range or Q3–Q1
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Fig. 3 Variation in age-standardized death rates in Europe,
1901–2008, infectious and cardiovascular diseases, by gender
a Infectious diseases, men b Infectious diseases, women c Cardiovas-
cular diseases, men d Cardiovascular diseases, women. Notes: ASDR
age-standardized death rate, Q1 age-standardized death rate at first
quartile, Q2 age-standardized death rate at second quartile or median,
Q3 age-standardized death rate at third quartile
Table 2 Variation in national income and association with life expectancy in Europe, 1900–2008
1900 1910 1920 1930 1939 1950 1960 1970 1980 1990 2000 2008
GDP
Average GDP 2158 2479 2737 3170 3859 3893 5539 7620 10614 10341 11294 14668
IQR of GDP (Q3-Q1) 1550 1666 1911 2474 2769 3274 4347 4691 8130 10286 15156 14532
Association with life expectancy, men
Correlation coefficient 0.31 0.54 0.73 0.83 0.83 0.81 0.50 0.48 0.63 0.61 0.71 0.78
Regression coefficient 1.44 3.48 4.70 3.46 3.74 1.80 0.65 0.49 0.47 0.48 0.51 0.54
Regression coefficient, s.e. 1.33 1.55 1.26 0.56 0.65 0.29 0.15 0.13 0.09 0.08 0.06 0.08
Association with life expectancy, women
Correlation 0.41 0.59 0.73 0.85 0.88 0.85 0.68 0.59 0.77 0.71 0.79 0.84
Regression coefficient 2.21 4.17 4.82 3.50 3.28 1.84 0.82 0.60 0.53 0.43 0.37 0.37
Regression coefficient, s.e. 1.48 1.64 1.29 0.52| 0.45 0.25 0.14 0.12 0.06 0.05 0.04 0.04
GDP gross domestic product in 1990 international dollars per capita, IQR inter-quartile range, Regression coefficient slope parameter (in years
per 1000 dollars), s.e. standard error
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national income. The underlying mechanisms, however, are
rather different. The increase in the inter-quartile range of
life expectancy in the first decades of the 20th century can be
predicted from the change in the relation between GDP and
life expectancy: even with each country’s GDP held
constant, the expected values of life expectancy still rise
substantially in this period (Fig. 4b). This is due to the fact
that the association between GDP and life expectancy, as
expressed in the slope parameter, becomes stronger during
this time-period (Table 2). On the other hand, the increase of
the inter-quartile range of life expectancy after 1970 appears
to be primarily due to a rising gap in national income between
countries: even with the regression parameters held constant,
the expected values of life expectancy rise dramatically in
this period (Fig. 4b). This is explained by the fact that since
1980 the inter-quartile range of GDP has increased enor-
mously (Table 2). It is only because the association with
GDP has become weaker over time that the actual inter-
quartile range of life expectancies in 2008 is between 5 and
8 years (Table 1), not 26 years (Fig. 4b).
Discussion and conclusions
Summary of main findings
During the first decades of the 20th century, variation in
life expectancy in Europe increased to reach peak values
around 1920, then decreased to reach its lowest values in
1960 (among men) and 1970 (among women), and finally
increased strongly again. The first widening occurred in a
period with rapid declines in age-standardized mortality,
and was due to less rapid declines in mortality in Southern
and Central and Eastern Europe, particularly from infec-
tious diseases. The second widening occurred in a period of
renewed mortality decline, and was due to stagnating or
increasing mortality in Central and Eastern Europe, par-
ticularly from cardiovascular diseases. During the whole
study-period differences between countries in national
income increased. The first widening of inequalities in life
expectancy coincided with an increasing strength of the
national income—life expectancy relation, and the second
with an exceptionally strong rise of between-country dif-
ferences in national income.
Limitations
A major strength of our study is that we have brought
together all European life expectancy data with docu-
mented validity. The downside of this is that there are gaps
in the available data. Before World War II, our coverage of
Europe is much more complete for Western than for
Central and Eastern Europe, both with life expectancy data
and with data on mortality by cause of death. For this
period, the life expectancy dataset only partly covers the
(then) Soviet Union, and the cause-of-death dataset does
not cover the Soviet Union at all. The analysis of data for
Western Europe only, however, allowed us to separate out
the trends in Western Europe from those in Central and
Eastern Europe, and clearly showed that the first episode of
divergence probably occurred in the whole of Europe,
while the second episode was limited to Central and
Eastern Europe.
Period life expectancy, the metric we used in our anal-
yses, is a commonly used, reliable and easily interpretable
summary measure of the mortality conditions applying to a
Fig. 4 Variation in observed life expectancy versus variation in
expected life expectancy in Europe, 1900–2008, by gender
a. Observed life expectancy versus life expectancy expected on the
basis of current GDP and current GDP—life expectancy relation
b Life expectancy expected on the basis of 1950 GDP and current
GDP—life expectancy relation, and life expectancy expected on the
basis of current GDP and 1950 GDP—life expectancy relation
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particular point in time [29]. It should, however, not be
interpreted as an estimate of the number of years that
babies born in a particular year can expect to live. Other
limitations of this measure are that tempo effects can dis-
tort the measurement of life expectancy in times of rapidly
declining or increasing mortality rates [30, 31], and that at
lower rates of mortality larger and larger declines are
necessary for one unit increase in life expectancy [29].
Despite the fact that the latter phenomenon drives life
expectancy to convergence, we observed a substantial
widening over recent decades, caused by a substantial
widening of the underlying mortality rates (Fig. 2).
Our analysis of cause-of-death data used routinely
registered information which is of uncertain validity,
particularly in the earlier parts of the study-period.
Because our analysis was limited to two broad groups of
causes of death, however, the results are unlikely to be
seriously biased. Because we used a careful reconstruction
of the code numbers pertaining to infectious and cardio-
vascular diseases in previous editions of the International
Classification of Diseases [25], changes in classification
between editions are also unlikely to have affected our
results.
Our analysis of the association between life expec-
tancy and national income is based on cross-sectional
data, and we cannot assume that these associations are a
good representation of the underlying causal relation-
ships. There may be confounding by third factors that are
associated with both national income and life expectancy,
such as levels of education [32], or there may be bias
from reverse causality if increased life expectancy, or
improved population health generally, contributes to a
higher national income [33–35]. That caution in inter-
pretation is needed is also clear from the fact that only
part of the rise in life expectancy between successive
points in time can be explained from rises in national
income and the cross-sectional association between
national income and life expectancy [36], and that lon-
gitudinal associations between changes in national
income and changes in life expectancy are usually
weaker than cross-sectional associations [37]. Neverthe-
less, there is scientific consensus that economic pros-
perity is one of the most important determinants of
population health [38], and use of these associations for
exploratory purposes as in this paper is certainly war-
ranted. Remarkably, and in contrast to what is seen in
world-wide analyses also covering low-income countries
[36, 39, 40], the relation between national income and
life expectancy continues to be approximately linear
within Europe [41], as can also indirectly be inferred
from the high correlation between GDP and life expec-
tancy even in 2008 (Table 2).
Interpretation
Our results suggest that both episodes of widening differ-
ences in life expectancy can plausibly be seen as resulting
from differences between countries in timing of epidemi-
ologic transitions. The first episode was partly due to earlier
or more rapid decline of infectious disease mortality in
Northwestern Europe, as compared to Southern and Central
and Eastern Europe. The second episode was partly due to an
earlier decline of cardiovascular disease mortality in Wes-
tern Europe, as compared to Central and Eastern Europe.
Although this suggests a common explanation of both
episodes, at least at a very general level, we also found two
important differences between the two episodes which cast
doubt on a common explanation. The second episode is
partly due to rising mortality in some countries (which we
did not observe in the first episode), and the second episode
appears to have been fuelled by a rising gap in income
(while the first episode could statistically be attributed
mainly to an increase in the strength of the association
between national income and life expectancy).
The first difference between both episodes, if seen in
isolation from the second difference, could be due to the
different time-windows in which they were observed. The
first episode occurred during the last decades of infectious
disease mortality decline, and there may have been earlier
instances (or an earlier start) of widening disparities in life
expectancy during the 19th century, unobserved in our
study, that were due to rising mortality in some countries
and declining mortality in others. An unpublished paper
analyzing European trends in life expectancy since the
middle of the 19th century suggests that there was an
earlier episode of widening around 1875 [42], and some
studies have found that 19th century urbanization may have
caused a rise in mortality in some countries [43]. The
second episode occurred during what may in the future turn
out to be the first decades of cardiovascular disease mor-
tality decline, and during later stages of this transition we
may see a further widening primarily due to differential
mortality decline.
The second difference, however, does indicate that these
two episodes have at least a partly different explanation.
The first episode coincided with a change in the association
between national income and life expectancy, in which the
marginal benefits of a higher national income in terms of
increased life expectancy seem to have become much lar-
ger. In 1900, a I$1000 higher national income was asso-
ciated with 1.4 (men) to 2.2 (women) years of extra life
expectancy, and this difference had more than doubled to
4.7 and 4.8 years respectively in 1920 (Table 2). This
suggests that important technical or organizational inno-
vations had taken place that lowered the cost or raised the
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effectiveness of health interventions. Historical studies
have documented that innovations implemented in this
period were part of the public health revolution (clean
drinking water and sanitation, improvements in housing
and working conditions, mother and child care, personal
hygiene, …) [28, 44, 45]. This may have allowed countries
with a higher national income to derive much more health
benefit from their higher income in this period, with poorer
countries following as soon as their rising incomes allowed
them to.
The second episode of widening disparities in life
expectancy, however, coincided with a rising gap in
income which was caused by the economic stagnation and
subsequent impoverishment of a part of Europe preceding
and following the collapse of the Soviet Union (Table 2)
[12, 26]. Although this relative and then absolute economic
downturn was temporary, it laid the basis for an enormous
gap in national income that, as our results suggest, in itself
may be sufficient to explain the life expectancy gap
(Fig. 4a). This was not a simple delay in epidemiologic
transition but an actual setback (Figs. 1 and 3c). Whether
these widening disparities in life expectancy were really
caused by widening income disparities cannot be inferred
from this analysis. As mentioned in the Introduction,
unfavorable trends in mortality in Central and Eastern
Europe have been attributed to a range of factors linked to
the political and economic situation in the communist and
post-communist era, such as dietary problems, excessive
alcohol consumption, lack of access to adequate health
care, unemployment, poverty and psychosocial stress
[8–12]. All of these may partly have been determined by
stagnating or declining national incomes, or, alternatively,
the latter may only act as a marker for unfavorable social
trends underlying both the economic and health perfor-
mance of communist and post-communist countries.
The absence of a change in the strength of the associ-
ation between national income and life expectancy sug-
gests that mortality decline in recent decades was not
primarily driven by innovations that increased the marginal
benefits of a higher national income. Instead, innovations
appear to have required investments that were only possi-
ble in countries with rapidly rising incomes, like those in
Western Europe. This is compatible with a substantial role
of medical care in the decline of cardiovascular disease
mortality [46–48]. In an additional analysis we therefore
tested the hypothesis that part of the widening gap in life
expectancy is due to widening between-country differences
in medical care, by studying trends in health care
expenditure.
Reliable data on health care expenditure in Central and
Eastern Europe are only available since 1995, and show
that the inter-quartile range of health care expenditure as a
percentage of national income in Europe as a whole rose
from 2.4 % in 1995 to 2.9 % in 2008 (data from the
World Health Organization Health for All Database
(http://data.euro.who.int/hfadb/)). This represents a huge
increase in absolute disparities in health care expenditure
(in Euros per capita) (cf. Table 2). While this appears to
confirm our hypothesis, the same dataset shows that
between-country differences in smoking, as indicated by
the inter-quartile range of the number of cigarettes smoked
per capita per year, also increased substantially (results not
shown). Further study of the explanation of the widening
gap in life expectancy in Europe, taking into account the
changing relation with economic factors [49], is therefore
necessary.
What can be done to close the current health divide
within Europe? A recent review commissioned by the
World Health Organization (WHO) recommends action on
health care as well as on lifestyle factors, but moves
beyond these immediate causes to also address some of the
underlying social, economic and political determinants.
Examples of policy actions believed to help improving
health in Central and Eastern Europe include reducing
poverty and strengthening social protection, more stringent
tobacco and alcohol control, and ensuring universal health
care coverage [50]. International collaboration, supported
by WHO and the European Union, will be needed to pro-
mote mutual learning and encourage sharing of resources.
Conclusions
Despite some similarities, differences between both epi-
sodes of widening differences in life expectancy cast doubt
on the idea that they have similar explanations. Interpreting
the recent widening in terms of a ‘normal’ delay of epi-
demiological transitions related to the necessary diffusion
of innovations across the European subcontinent, carries
the risk that one would see this divergence as a phenom-
enon that will automatically disappear when a natural
process of diffusion is allowed to continue. Our results
suggest that this may well be a romantic illusion. Instead,
the current episode of widening differences in life expec-
tancy is an alarming phenomenon that should be a main
focus of European policy making.
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